BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11190904)

  • 1. Anticoagulant and antiprotease effects of a novel heparinlike compound from shrimp (Penaeus brasiliensis) and its neutralization by heparinase I.
    Demir M; Iqbal O; Dietrich CP; Hoppensteadt DA; Ahmad S; Daud AN; Fareed J
    Clin Appl Thromb Hemost; 2001 Jan; 7(1):44-52. PubMed ID: 11190904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulant and antiprotease profiles of a novel natural heparinomimetic mannopentaose phosphate sulfate (PI-88).
    Demir M; Iqbal O; Hoppensteadt DA; Piccolo P; Ahmad S; Schultz CL; Linhardt RJ; Fareed J
    Clin Appl Thromb Hemost; 2001 Apr; 7(2):131-40. PubMed ID: 11292191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and pharmacologic profile of tinzaparin and a comparable low-molecular-weight bacterial sulfaminoheparosan.
    Maddineni J; Ma Q; Hoppensteadt DA; Demir M; Manoni M; Cornelli U; Fareed J
    Clin Appl Thromb Hemost; 2004 Jan; 10(1):27-37. PubMed ID: 14979402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andexanet Alfa Neutralizes the Anticoagulant Effects of Unfractionated Heparin of Bovine, Ovine and Porcine Origin Almost as Protamine Sulfate.
    Siddiqui F; Hoppensteadt D; Jeske W; Ramacciotti E; Tafur A; Fareed J
    Clin Appl Thromb Hemost; 2024; 30():10760296241247558. PubMed ID: 38656136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of different anticoagulant agents on fibrinopeptide a generation.
    Tobu M; Iqbal O; Messmore HL; Ma Q; Hoppensteadt DA; Fareed J
    Clin Appl Thromb Hemost; 2003 Oct; 9(4):273-92. PubMed ID: 14653437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of heparin from tuna skins.
    Jeske WP; McDonald MK; Hoppensteadt DA; Bau EC; Mendes A; Dietrich CP; Walenga JM; Coyne E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):137-45. PubMed ID: 17456622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a synthetic factor Xa inhibitor (JTV-803) on various laboratory tests.
    Tobu M; Iqbal O; Hoppensteadt DA; Shultz C; Jeske W; Fareed J
    Clin Appl Thromb Hemost; 2002 Oct; 8(4):325-36. PubMed ID: 12516682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural features and anticoagulant activities of a novel natural low molecular weight heparin from the shrimp Penaeus brasiliensis.
    Dietrich CP; Paiva JF; Castro RA; Chavante SF; Jeske W; Fareed J; Gorin PA; Mendes A; Nader HB
    Biochim Biophys Acta; 1999 Aug; 1428(2-3):273-83. PubMed ID: 10434045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Product individuality of commercially available low-molecular-weight heparins and their generic versions: therapeutic implications.
    Maddineni J; Walenga JM; Jeske WP; Hoppensteadt DA; Fareed J; Wahi R; Bick RL
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):267-76. PubMed ID: 16959680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.
    Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF
    Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulant activity of low-molecular-weight heparins obtained using a hydrolase complex].
    Drozd NN; Tolstenkov AS; Bannikova GE; Miftakhova NT; Lapikova ES; Makarov VA; Varlamov VP
    Eksp Klin Farmakol; 2007; 70(6):19-24. PubMed ID: 18318190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa.
    Siddiqui F; Tafur A; Bontekoe E; Iqbal O; Jeske W; Mehrotra S; Hoppensteadt D; Ramacciotti E; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029619895120. PubMed ID: 31914798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of the anticoagulant activities of the low molecular weight heparin fractions and fragments with flavobacterial heparinase.
    Yang VC; Bernstein H; Cooney CL; Kadam JC; Langer R
    Thromb Res; 1986 Dec; 44(5):599-610. PubMed ID: 3810562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa.
    Lewis J; Iqbal O; Jeske W; Hoppensteadt D; Siddiqui F; Fareed J
    Clin Appl Thromb Hemost; 2022; 28():10760296221099934. PubMed ID: 35535398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro coagulant and amidolytic methods for evaluating the activity of heparin and a low molecular weight derivative (PK 10169).
    Walenga JM; Fareed J; Hoppensteadt DA
    Semin Thromb Hemost; 1985 Jan; 11(1):17-25. PubMed ID: 3883497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays.
    Coppell JA; Thalheimer U; Zambruni A; Triantos CK; Riddell AF; Burroughs AK; Perry DJ
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):97-104. PubMed ID: 16479191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies on the biochemistry and pharmacology of low molecular weight heparins.
    Jeske W; Fareed J
    Semin Thromb Hemost; 1999; 25 Suppl 3():27-33. PubMed ID: 10549713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The establishment and validation of efficient assays for anti-IIa and anti-Xa activities of heparin sodium and heparin calcium.
    Suzuki T; Ishii-Watabe A; Hashii N; Nakagawa Y; Takahashi T; Ebisawa A; Nishi S; Fujita N; Bando A; Sekimoto Y; Miyata K; Endo T; Otsu T; Sugimoto S; Kondou T; Fujita Y; Miyanaga N; Mashimo M; Shimada N; Yoden H; Shimamura H; Kurata Y; Koyama S; Kawasaki N
    Biologicals; 2013 Nov; 41(6):415-23. PubMed ID: 24095600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.